Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Hormone Replacement Paradigm: Physiologic Restoration Using Compounded Biomimetic Estradiol, Progesterone and Testosterone Applied Transdermally in a Rhythmic Dose

NCT04190927 is registered in ClinicalTrials.gov with Women's Hormone Network as lead sponsor.

NCT NCT04190927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04190927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Hormone Replacement Paradigm: Physiologic Restoration Using Compounded Biomimetic Estradiol, Progesterone and Testosterone Applied Transdermally in a Rhythmic Dose
Lead sponsor
Women's Hormone Network
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2020
Completion date
August 1, 2023
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

menopause, menopause related conditions, perimenopausal disorder